Clinical Trial Detail

NCT ID NCT02833883
Title Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

prostate cancer

Therapies

CC-115 + Enzalutamide

Age Groups: adult senior

No variant requirements are available.